SHCBP1 drives tumor progression in triple-negative breast cancer
{{output}}
Backgrounds: Triple-negative breast cancer (TNBC) represents the most aggressive breast cancer subtype. The limited treatment options underscore the urgent need to explore novel molecular targets to combat TNBC progression. This ... ...
